Obstructed Megaureter 

  • Author: Robert A Mevorach, MD; Chief Editor: Edward David Kim, MD, FACS   more...
 
Updated: Jul 12, 2011
 

Background

In 1923, Caulk described a patient with distal ureteral dilatation without evidence of hydronephrosis and coined the term megaloureter. Thirty years later, Swenson postulated a neurologic etiology for both megacolon and megaureter and treated such patients with urinary diversion, ureteral substitution, and ileal augmentation to provide peristalsis. Clinical management of megaureter evolved over the next two decades. Stephens, Nesbitt, and Withycombe advised observation and double voiding to reduce the incidence of urinary tract infections (UTIs) and admonished those who practiced the surgical approaches of the period.

Next

History of the Procedure

Johnston, Hendren and Henderson, and Creevy advanced the field of surgical management of megaureter through aggressive ureteral tailoring and the adaptation of experience in ureteral reimplantation for vesicoureteral reflux.[1, 2] Williams and Hulme-Moir launched the era of modern care of the primary megaureter by demonstrating a spectrum of this disorder that could be managed with observation in less-severe cases, with excellent clinical and radiographic outcomes.[3]

Obstructive megaureter is, in itself, a misnomer because most cases demonstrate partial obstruction. Although this entity is rare, the principles of its evaluation and management may apply to a wide spectrum of ureteral abnormalities; consequently, a thorough understanding has a wide application.

Previous
Next

Problem

Megaureter, the accepted term for the dilated ureter, is divided into primary (congenital) and secondary categories. Each category is further subdivided into (1) refluxing nonobstructing megaureter and (2) nonrefluxing obstructing megaureter. These distinctions are based on radiographic and clinical findings. This article discusses primary obstructive megaureter.

Previous
Next

Epidemiology

Frequency

The incidence of obstructed megaureter is 1 per 10,000 population. The male-to-female ratio is 1.2-4.8:1. The left-to-right ratio is 1.7-4.5:1. Obstruction is bilateral in 10%-20% of obstructed megaureter cases.

Previous
Next

Etiology

Primary obstructing megaureter is caused by a structural alteration in the muscular layers of the distal ureter, which is characterized, to varying degrees, by diminished or absent longitudinal muscle fibers, hypertrophied or hyperplastic circular muscle fibers, or increased connective-tissue deposition. These changes are defined pathologically and may represent either an arrest of normal development or an intrauterine response of the ureter to ongoing obstruction.

Animal models of congenital megaureter are lacking, but Mortell et al have developed a rat model of prenatal doxorubicin (Adriamycin) exposure that may help elucidate the etiology of this developmental defect.[4]

Previous
Next

Pathophysiology

Partial obstruction in the abnormal distal segment of the ureter leads to progressive dilatation. Progression to hydronephrosis (ie, dilation of the renal pelvis and calyces) occurs when the ureter no longer accommodates resistance to urinary drainage; pressure is then conveyed more proximally. Complete obstructions are rare and are invariably associated with a nonfunctioning renal unit at diagnosis.

Primary obstructed megaureters enter the bladder in a normal location on the trigone, with the ureteral orifice appearing unaffected. This entity should not be confused with ectopic megaureters that end in an abnormal location within the lower urinary tract or other mesonephric anlage.

Previous
Next

Presentation

Children with an obstructed megaureter may present with vague abdominal pain, hematuria, UTI, fever of unknown origin, or an abdominal mass. The primary presentation, antenatal hydronephrosis, is diagnosed with prenatal ultrasonography.

Prenatal ultrasonography reveals an indication of an underlying genitourinary abnormality in as many as 1 per 100 births; most of these are hydronephroses. Clinical presentation of primary megaureter, which is less common since the advent of fetal ultrasonography, includes the following:

  • UTI
  • Hematuria
  • Pyuria
  • Flank mass
  • Fever of unknown origin
  • Abdominal or pelvic pain
  • Abdominal mass
  • Serendipitous identification on imaging (eg, ultrasonography; CT scanning; kidneys, ureters, and bladder [KUB] radiography; bone scan)
Previous
Next

Indications

The diagnosis of obstructed megaureter is established radiographically based on definition of a dilated distal ureteral segment that inserts into a normal ureteral meatus. Findings on endoscopy reveal that these ureteral tunnels are not obstructed to retrograde passage of a ureteral catheter or probe. However, when viewed fluoroscopically, the peristalsis of the ureter, which halts abruptly at the narrowing, can be observed. Associated abnormalities may include the following:

Increasing ureteral dilation warrants consideration of renal and ureteral drainage. Megaureters detected in neonates and infants may require drainage for infections that do not respond to antibiotics alone. Additionally, the massively dilated ureter may be decompressed with ureterostomy, pyelostomy, or nephrostomy drainage, which often allows a substantial decrease in ureteral size and greatly reduces ureteral bulk during both tailoring and reimplantation.

Previous
Next

Relevant Anatomy

Congenital and acquired lesions that cause obstruction of the distal ureter have been reported, and, in certain instances, these lesions confound the diagnosis. While a primary obstructed megaureter may subtend both the single and the duplicated collecting systems, it is associated most commonly with a single system.

  • Ureteroceles are more common in females and are associated with the upper-pole ureter of a complete duplication of the renal collecting system. Protrusion of the dilated distal ureter within the bladder or urethral lumen defines this lesion.
  • Ureteral valves, membranes, and polyps demonstrate intrinsic filling defects that differentiate these lesions from primary megaureter. These lesions are rare.
  • Ureteral calculi may become impacted in the distal ureter and may be associated with scarring. The resultant ureteral narrowing may obscure the underlying diagnosis; however, management principles are consistent, regardless of the underlying pathology.
Previous
Next

Contraindications

In mild cases of obstructed megaureter, surgery may be unnecessary. Physicians may monitor symptoms, perform periodic radiologic imaging, and administer antibiotic prophylaxis.

Document that patients are free of infection at the time of reconstruction.

Previous
Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Robert A Mevorach, MD  Associate Professor, Departments of Urology and Pediatrics, University of Rochester School of Medicine

Robert A Mevorach, MD is a member of the following medical societies: American Academy of Pediatrics and American Urological Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Bradley Fields Schwartz, DO, FACS  Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine

Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Association of Military Osteopathic Physicians and Surgeons, Endourological Society, Society of Laparoendoscopic Surgeons, and Society of University Urologists

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

J Stuart Wolf Jr, MD, FACS  The David A Bloom Professor of Urology, Director, Division of Endourology and Stone Disease, Department of Urology, University of Michigan Medical School

J Stuart Wolf Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, Society of University Urologists, and Society of Urologic Oncology

Disclosure: Nothing to disclose.

Chief Editor

Edward David Kim, MD, FACS  Professor of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine; Consulting Staff, University of Tennessee Medical Center

Edward David Kim, MD, FACS is a member of the following medical societies: American College of Surgeons, American Society for Reproductive Medicine, American Society of Andrology, American Urological Association, Sexual Medicine Society of North America, and Tennessee Medical Association

Disclosure: Lilly Consulting fee Advisor; Astellas Consulting fee Speaking and teaching; Watson Consulting fee Speaking and teaching; Allergan Consulting fee Speaking and teaching

References
  1. Hendren WH, Henderson BM. Recent advances in pediatric surgery. Am J Surg. Sep 1969;118(3):338-55. [Medline].

  2. Creevy CD. The atonic distal ureteral segment (ureteral achalasia). J Urol. Mar 1967;97(3):457-63. [Medline].

  3. Williams DI, Hulme-Moir I. Primary obstructive mega-ureter. Br J Urol. Apr 1970;42(2):140-9. [Medline].

  4. Mortell A, Fourcade L, Solari V, Puri P. Bilateral megaureters in the Adriamycin rat model. Pediatr Surg Int. Mar 2005;21(3):212-6. [Medline].

  5. Kajbafzadeh AM, Payabvash S, Salmasi AH, Arshadi H, Hashemi SM, Arabian S, et al. Endoureterotomy for treatment of primary obstructive megaureter in children. J Endourol. Jul 2007;21(7):743-9. [Medline].

  6. Tatlisen A, Ekmekçioglu O. Direct nipple ureteroneocystostomy in adults with primary obstructed megaureter. J Urol. Mar 2005;173(3):877-80. [Medline].

  7. Arena F, Baldari S, Proietto F, Centorrino A, Scalfari G, Romeo G. Conservative treatment in primary neonatal megaureter. Eur J Pediatr Surg. Dec 1998;8(6):347-51. [Medline].

  8. Bakker HH, Scholtmeijer RJ, Klopper PJ. Comparison of 2 different tapering techniques in megaureters. J Urol. Nov 1988;140(5 Pt 2):1237-9. [Medline].

  9. Bapat S, Bapat M, Kirpekar D. Endoureterotomy for congenital primary obstructive megaureter: preliminary report. J Endourol. Apr 2000;14(3):263-7. [Medline].

  10. Belman AB. Megaureter. Classification, etiology, and management. Urol Clin North Am. Oct 1974;1(3):497-513. [Medline].

  11. DeFoor W, Minevich E, Reddy P, Polsky E, McGregor A, Wacksman J, et al. Results of tapered ureteral reimplantation for primary megaureter: extravesical versus intravesical approach. J Urol. Oct 2004;172(4 Pt 2):1640-3; discussion 1643. [Medline].

  12. Erbas B, Royal SA, Joseph D. Scintigraphic evaluation of obstructing primary megaureter with Tc-99m MAG3. Clin Nucl Med. Jun 1997;22(6):355-8. [Medline].

  13. Lee SD, Akbal C, Kaefer M. Refluxing ureteral reimplant as temporary treatment of obstructive megaureter in neonate and infant. J Urol. Apr 2005;173(4):1357-60; discussion 1360. [Medline].

  14. Lockhart JL, Politano VA. Management of massively dilated ureters in children. Urology. Sep 1981;18(3):229-34. [Medline].

  15. McLaughlin AP 3rd, Pfister RC, Leadbetter WF, Salzstein SL, Kessler WO. The pathophysiology of primary megaloureter. J Urol. May 1973;109(5):805-11. [Medline].

  16. Patti G, Menghini ML, Todini AR, Marrocco G, Calisti A. The role of the renal resistive index ratio in diagnosing obstruction and in the follow-up of children with unilateral hydronephrosis. BJU Int. Feb 2000;85(3):308-12. [Medline].

  17. Payabvash S, Kajbafzadeh AM, Tavangar SM, Monajemzadeh M, Sadeghi Z. Myocyte apoptosis in primary obstructive megaureters: the role of decreased vascular and neural supply. J Urol. Jul 2007;178(1):259-64; discussion 264. [Medline].

  18. Rabinowitz R, Barkin M, Schillinger JF, Jeffs RD. Surgical treatment of the massively dilated primary megaureter in children. Br J Urol. Feb 1979;51(1):19-23. [Medline].

  19. Rabinowitz R, Barkin M, Schillinger JF, Jeffs RD, Cook GT. Surgical treatment of the massively dilated ureter in children. Part II. Management by primary reconstruction. J Urol. Sep 1977;118(3):436-9. [Medline].

  20. Rabinowitz R, Barkin M, Schillinger JF, Jeffs RD, Cook GT. The influence of etiology on the surgical management and prognosis of the massively dilated ureter in children. J Urol. Jun 1978;119(6):808-13. [Medline].

  21. Shukla AR, Cooper J, Patel RP, Carr MC, Canning DA, Zderic SA, et al. Prenatally detected primary megaureter: a role for extended followup. J Urol. Apr 2005;173(4):1353-6. [Medline].

  22. Stehr M, Metzger R, Schuster T, Porn U, Dietz HG. Management of the primary obstructed megaureter (POM) and indication for operative treatment. Eur J Pediatr Surg. Feb 2002;12(1):32-7. [Medline].

  23. Tanagho EA. Embryologic basis for lower ureteral anomalies: a hypothesis. Urology. May 1976;7(5):451-64. [Medline].

  24. Thompson A, Gough DC. The use of renal scintigraphy in assessing the potential for recovery in the obstructed renal tract in children. BJU Int. Jun 2001;87(9):853-6. [Medline].

Previous
Next
 
This renal sonogram demonstrates hydronephrosis with good parenchymal thickness and retained corticomedullary differentiation.
This pelvic sonogram reveals the classic spindle configuration of primary obstructed megaureter.
This panel from a technetium Tc 99m mercaptotriglycylglycine (MAG-3) renal scan shows differential obstruction of each kidney. While the classic image of a primary obstructed megaureter is shown on the left, a severe congenital ureteropelvic junction obstruction is present in the contralateral kidney. (These images are viewed with the left kidney on the left portion of each panel and the right kidney on the right portion of each panel.)
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.